Volume 148, Issue 1, Pages (January 2015)

Slides:



Advertisements
Similar presentations
Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)
Advertisements

Dr. Marco Matos JOURNAL CLUB GCUH 4/07/14.
Abnormal Liver Tests and Fatty Liver on Ultrasound
Volume 146, Issue 4, Pages (April 2014)
Immunology and the Lynch Syndrome
Volume 148, Issue 1, Pages e2 (January 2015)
Naveen B. Krishna, Laura Gardner, Brian T. Collins, Banke Agarwal 
Christoph Lübbert, Babett Holler  Gastroenterology 
Community Colonoscopy: A Gordian Knot?
Covering the Cover Gastroenterology
Outcomes Among Living Liver Donors
Covering the Cover Gastroenterology
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Rana Sabbagh, Edi Levi, Fadi Antaki  Gastroenterology 
Making Sense of HDAC2 Mutations in Colon Cancer
Volume 134, Issue 1, Pages (January 2008)
Volume 142, Issue 2, Pages (February 2012)
Unusual Thickened Gastric Folds in a Patient With Breast Cancer
Volume 154, Issue 4, Pages e1 (March 2018)
Clinical Challenges and Images in GI
Volume 147, Issue 3, Pages (September 2014)
Eva Wertheimer, Marcelo G. Kazanietz  Gastroenterology 
Volume 155, Issue 4, Pages (October 2018)
Volume 153, Issue 3, Pages e16-e17 (September 2017)
Volume 135, Issue 4, Pages (October 2008)
Volume 150, Issue 4, Pages (April 2016)
Accuracy of the ALFSG Index as a Triage Marker in Acute Liver Failure
Ajay Goel, Takeshi Nagasaka, Jennifer Spiegel, Richard Meyer, Warren E
An Unusual Incidental Finding in a Patient With Colon Perforation
Volume 137, Issue 4, Pages (October 2009)
Multiple Masses in the Colon of a Patient With Ulcerative Colitis
Volume 155, Issue 5, Pages (November 2018)
Volume 151, Issue 1, Pages e5 (July 2016)
Colon Cancer: An Update and Future Directions
Volume 145, Issue 1, Pages (July 2013)
Immunology and the Lynch Syndrome
Volume 136, Issue 1, Pages (January 2009)
Volume 155, Issue 6, Pages (December 2018)
Covering the Cover Gastroenterology
Volume 145, Issue 2, Pages e2 (August 2013)
Laura Rotundo, Sushil Ahlawat  Gastroenterology 
The 75th Diamond Anniversary of Gastroenterology: 1943–2018
Stephen J. Rulyak, David A. Lieberman, Edward H. Wagner, Margaret T
Amir Shlomai, Ana Tobar, Ofer Benjaminov  Gastroenterology 
Coffee and Colorectal Cancer: Grounds for Prevention?
Volume 133, Issue 2, Pages (August 2007)
Targeted Therapies for Hepatocellular Carcinoma
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Methionine Intake and Pancreatic Cancer Risk: Digesting the Evidence
Volume 149, Issue 6, Pages (November 2015)
Volume 136, Issue 7, Pages (June 2009)
Volume 132, Issue 1, Pages (January 2007)
Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C  Gowtham A. Rao, Prashant K. Pandya  Gastroenterology 
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Richard J. Saad, William D. Chey  Gastroenterology 
Volume 137, Issue 2, Pages (August 2009)
Changing of the Guards: 2011–2016 Gastroenterology Team
Daniel Mønsted Shabanzadeh, Lars Tue Sørensen, Torben Jørgensen 
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Cancer Costs Projected to Reach at Least $158 Billion in 2020
Issue Highlights Clinical Gastroenterology and Hepatology
Volume 138, Issue 6, Pages (May 2010)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Reinvesting in US Biomedical Research—The Time is Now
Electronic Clinical Challenges and Images in GI
Volume 151, Issue 2, Pages (August 2016)
Microsatellite Instability in Interval Colon Cancers
Presentation transcript:

Volume 148, Issue 1, Pages 88-99 (January 2015) Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes  Frank A. Sinicrope, Qian Shi, Thomas C. Smyrk, Stephen N. Thibodeau, Rodrigo Dienstmann, Justin Guinney, Brian M. Bot, Sabine Tejpar, Mauro Delorenzi, Richard M. Goldberg, Michelle Mahoney, Daniel J. Sargent, Steven R. Alberts  Gastroenterology  Volume 148, Issue 1, Pages 88-99 (January 2015) DOI: 10.1053/j.gastro.2014.09.041 Copyright © 2015 AGA Institute Terms and Conditions

Figure 1 (A) Stage III colon cancers were categorized into 5 subtypes based on mutations in BRAF (V600E) and KRAS (exon 2) and MMR status. BRAFV600Eand KRAS mutations were mutually exclusive. (B) DFS is shown by molecular subtype in patients treated in an adjuvant trial of FOLFOX-based chemotherapy. Gastroenterology 2015 148, 88-99DOI: (10.1053/j.gastro.2014.09.041) Copyright © 2015 AGA Institute Terms and Conditions

Figure 2 DFS by molecular subtypes among (A) proximal or (B) distal stage III colon cancers. DFS by molecular subtypes among patients with stage III colon cancer and (C) 1–3 metastatic regional lymph nodes (N1) or (D) 4 or more metastatic regional lymph nodes (N2). Gastroenterology 2015 148, 88-99DOI: (10.1053/j.gastro.2014.09.041) Copyright © 2015 AGA Institute Terms and Conditions

Figure 3 Independent cohort of stage III colon cancer patients used for external validation of the subtype classifier. DFS is shown for the individual subtypes. Gastroenterology 2015 148, 88-99DOI: (10.1053/j.gastro.2014.09.041) Copyright © 2015 AGA Institute Terms and Conditions